Laser Power & Infra IPO GMP ₹36: 2026 listing cue

What is driving attention on the IPO

Laser Power & Infra’s initial public offering has drawn focus because grey market indicators have stayed positive through the bidding window. The IPO is for ₹742 crore and the company is described as an integrated manufacturer of power cables and conductors. The price band was fixed at ₹203 to ₹214 per equity share, with ₹214 as the upper end used for most GMP-based calculations. The issue opened on July 9, 2026 and was scheduled to close on July 13, 2026. Market participants have been tracking both subscription data and grey market premium (GMP) prints to gauge listing expectations.

Key dates investors tracked

The subscription window ran for three days and was set to close on Monday, July 13, 2026. The basis of allotment was expected to be finalised on Tuesday, July 14, 2026. Shares were expected to list on both NSE and BSE on Thursday, July 16, 2026. These dates became central for tracking GMP changes because grey market trading tends to react to demand signals near the close and allotment period. The IPO was also widely discussed as being in its “second day of bidding” when some of the stronger GMP movement was reported.

Price band, lot size, and minimum investment

Laser Power & Infra fixed the IPO price band at ₹203 to ₹214 per share. The minimum lot size mentioned was 70 shares. Based on the upper band, the minimum application amount was stated at ₹14,980. These are the reference points used in several GMP trackers and subscription updates for estimating potential listing prices.

Issue size and structure: fresh issue vs OFS

The IPO size was reported at ₹742 crore in multiple places. A breakdown was also provided: ₹542 crore as fresh issue and ₹200 crore as offer for sale (OFS) by existing shareholders. Another summary stated the composition as 73.0% fresh issue and 27.0% OFS, which aligns with the ₹542 crore and ₹200 crore split. The stated purpose of the fresh issue was mainly debt reduction, while the OFS allows existing shareholders to sell part of their stake.

Subscription snapshot: where demand showed up

On July 13, 2026, NSE data cited in the report showed bids for 8.71 crore shares against 2.55 crore shares on offer, translating to an overall subscription of 3.41 times as of 11:57 AM. In that snapshot, NIIs were the strongest bidders at 9.96 times their quota. Retail investors were subscribed 2.16 times. QIB participation was reported as relatively lower at 67% in the same update.

Some market trackers and separate summaries circulating alongside the IPO also mentioned much higher aggregate subscription figures such as 24.71 times or “subscribed 25x,” and one line claimed “strong QIB demand 54x.” These figures were presented without the same timestamped NSE context as the 3.41x update. Investors typically reconcile such differences by checking the latest exchange subscription files and the timestamp for the data being quoted.

Grey market premium (GMP): the range, not a single number

Multiple GMP prints were cited through the IPO period. One update stated the issue was commanding a GMP of ₹36, implying about a 17% premium over the upper price band of ₹214, with an estimated debut around ₹250 per share if sentiment held. Another day-2 update reported GMP at ₹33, up from ₹24 at the end of day 1, implying an estimated listing price of around ₹247, or a 15.42% gain versus ₹214.

A separate data point for July 13, 2026 cited the IPO price as ₹214 with GMP of ₹29 (13.55%), estimating a listing price of ₹243. Another report around the issue close said unlisted shares were trading at ₹242, implying GMP of ₹28 (13.08%) over ₹214. Some trackers also cited GMP values like ₹41 (18.90%) and an implied listing price of ₹255. Other snippets mentioned GMP at ₹18 (implying about ₹227) and ₹21 (about 10%).

GMP volatility: what the reported trend showed

The reported GMP moved sharply in the run-up to and during the IPO. It was cited at ₹28 on July 6, then down to ₹15 on July 7 and July 8, before rising to ₹24 on the IPO’s opening day and further to ₹33 on July 10. Another line stated the minimum GMP recorded was ₹10 and the maximum GMP reached ₹43. One Hindi update also mentioned a much higher GMP print of ₹93 with a potential listing price estimate of ₹667, which stands out from other calculations tied to the ₹214 band and should be treated as an outlier claim as presented.

Quick facts table: IPO terms and market indicators

Market impact: what the numbers implied

The key market signal in the coverage was that GMP stayed positive through most updates, with estimates of 8% to nearly 19% premium depending on the source and time. At a GMP of ₹36, the implied listing level was around ₹250, or roughly 17% above ₹214. At GMP of ₹29 to ₹33, implied levels were around ₹243 to ₹247, pointing to mid-teens percentage gains. Subscription data, where time-stamped, showed NII demand leading the book (9.96x) while QIB participation was lower (67%) as of late morning on July 13.

It was also noted that brokerages maintained a positive view citing valuations compared with peers, earnings growth, and a healthy order book providing revenue visibility over the next 12 to 18 months. These points were presented as reasons supporting investor interest, alongside the stated use of proceeds that included debt reduction.

Analysis: why the IPO data mattered for investors

Two threads dominated the public narrative: the subscription mix and the GMP trend. Stronger NII bidding, coupled with positive grey market prints, often signals demand for potential listing gains, though it does not guarantee performance. The variability in GMP figures shows how quickly sentiment can shift, especially near closing and allotment days. The IPO’s structure, with a majority fresh issue and a stated focus on reducing debt, also positioned the offer as partly balance-sheet focused rather than purely an exit for existing shareholders.

What to watch next

The next operational milestone mentioned was the finalisation of the basis of allotment on July 14, 2026. The key market milestone was the expected listing on July 16, 2026 on NSE and BSE. GMP is an unofficial indicator and can change quickly ahead of listing, so investors typically track final exchange subscription data, allotment outcomes, and listing-day demand and supply.